Effects of dietary dihydromyricetin supplementation on intestinal barrier and humoral immunity in growing-finishing pigs.

Anim Biotechnol

Key Laboratory for Animal Disease-Resistance Nutrition of China Ministry of Education, Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu, P. R. China.

Published: December 2022

In this study, we investigated the effect of dietary dihydromyricetin (DHM) supplementation on intestinal barrier and humoral immunity in growing-finishing pigs. The data showed that dietary DHM supplementation improved jejunal barrier function by upregulating the protein expressions of Occludin and Claudin-1 and the mRNA levels of and . Dietary DHM supplementation increased the amylase, lipase, sucrase and maltase activities and the mRNA expression of nutrient transporter (, , ) in the jejunum mucosa. Dietary DHM supplementation significantly reduced the population in the cecum and colon and increased the population in the cecum. In addition, dietary DHM supplementation increased the contents of butyric acid and valeric acid in cecum and colon. In serum, dietary DHM supplementation reduced interleukin-1β (IL-1β) content and increased interleukin-10 (IL-10), Immunoglobulin M (IgM) and Immunoglobulin A (IgA) contents ( 0.05). In addition, compared with the control group, dietary DHM supplementation improved secretory immunoglobulin A (sIgA) and interleukin-10 (IL-10) contents and down-regulated TNF-α protein expression in jejunum mucosa ( 0.05). Together, this study demonstrated that dietary DHM supplementation improved intestinal barrier function, digestion and absorption capacity and immune function in growing-finishing pigs.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10495398.2022.2099881DOI Listing

Publication Analysis

Top Keywords

dhm supplementation
32
dietary dhm
28
intestinal barrier
12
growing-finishing pigs
12
supplementation improved
12
supplementation
9
dietary dihydromyricetin
8
supplementation intestinal
8
barrier humoral
8
humoral immunity
8

Similar Publications

Article Synopsis
  • Early exposure to mother's own milk (MOM) in preterm infants aids in developing a better intestinal barrier, and the study hypothesizes that donor human milk (DHM) can have similar effects on intestinal permeability (IP).
  • The research involved 158 preterm infants, measuring IP via a sugar absorption test and assessing nutritional data; they found that diets with exclusive MOM or DHM led to lower IP compared to preterm formula.
  • Results indicate that a higher intake of MOM or DHM in the first 7-10 days post-birth fosters intestinal maturation, but this low IP does not correlate with reduced postnatal growth failure by the time of discharge.
View Article and Find Full Text PDF

Donor human milk practice in Indonesia: a media content analysis.

Front Nutr

September 2024

Research Division, Indonesian Breastfeeding Mother Association, Surabaya, Jakarta, Indonesia.

Introduction: Donor human milk (DHM) is recommended as the second-best alternative form of supplementation when a mother is unable to breastfeed directly. However, little is known about the experience of mothers and families in the communities regarding accessing and donating expressed breastmilk in Indonesia. This study aimed to identify the experience related to donor human milk in the society in Indonesia.

View Article and Find Full Text PDF

Objective: To evaluate the association between different types of human milk feeds and bronchopulmonary dysplasia (BPD) in preterm infants.

Methods: Data on dispensed mother's own milk (MOM) and donor human milk (DHM) from Leipzig Milk Bank for hospitalized infants with a gestational age (GA) ≤32 weeks observed from birth to 36 weeks' postmenstrual age or prior discharge were used. BPD was assessed based on documented International Statistical Classification of Diseases and Related Health Problems (ICD) diagnosis and on electronic hospital records (EHR) of data on ventilation and oxygen supplementation.

View Article and Find Full Text PDF

The World Health Organization (WHO) recommends exclusive breastfeeding for the first 6 months of life followed by complementary foods and sustained breastfeeding for at least 2 years, underscoring its pivotal role in reducing infant mortality and preventing various illnesses. This perspective delves into the intricate relationship between breastfeeding practices, early life antibiotic exposure, and infant gut microbiome development, highlighting their profound influence on child health outcomes. Antibiotics are extensively prescribed during pregnancy and childhood, disrupting the microbiome, and are related to increased risks of allergies, obesity, and neurodevelopmental disorders.

View Article and Find Full Text PDF

Background: There is an increasing acceptance and use of donor human milk (DHM) in healthy infants. This review investigates the benefits and risks of mothers' own milk (MOM) supplementation with DHM compared to infant formula (IF) in moderate-late preterm (MLP) and early term (ET) infants.

Methods: MEDLINE, EMBASE, CINAHL, Scopus, Cochrane CENTRAL and clinical trial registries were searched for studies published up to September 2023.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!